ZIMVIE INC (ZIMV) Stock Fundamental Analysis
NASDAQ:ZIMV - Nasdaq - US98888T1079 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to ZIMV. ZIMV was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ZIMV has an average financial health and profitability rating. ZIMV has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
ZIMV had positive earnings in the past year.
In the past year ZIMV had a positive cash flow from operations.
In the past 5 years ZIMV always reported negative net income.
Each year in the past 5 years ZIMV had a positive operating cash flow.
1.2 Ratios
ZIMV has a Return On Assets of -2.57%. This is in the better half of the industry: ZIMV outperforms 68.98% of its industry peers.
ZIMV has a better Return On Equity (-4.72%) than 70.05% of its industry peers.
ZIMV has a Return On Invested Capital of 0.77%. This is in the better half of the industry: ZIMV outperforms 65.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -4.72% | ||
| ROIC | 0.77% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 1.42%, ZIMV is doing good in the industry, outperforming 65.24% of the companies in the same industry.
ZIMV has a better Gross Margin (65.31%) than 67.91% of its industry peers.
In the last couple of years the Gross Margin of ZIMV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.42% | ||
| PM (TTM) | N/A | ||
| GM | 65.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
2. Health
2.1 Basic Checks
ZIMV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ZIMV has been increased compared to 1 year ago.
The number of shares outstanding for ZIMV has been increased compared to 5 years ago.
ZIMV has a better debt/assets ratio than last year.
2.2 Solvency
ZIMV has an Altman-Z score of 0.90. This is a bad value and indicates that ZIMV is not financially healthy and even has some risk of bankruptcy.
ZIMV has a Altman-Z score (0.90) which is comparable to the rest of the industry.
ZIMV has a debt to FCF ratio of 39.31. This is a negative value and a sign of low solvency as ZIMV would need 39.31 years to pay back of all of its debts.
ZIMV has a better Debt to FCF ratio (39.31) than 67.91% of its industry peers.
ZIMV has a Debt/Equity ratio of 0.53. This is a neutral value indicating ZIMV is somewhat dependend on debt financing.
ZIMV has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: ZIMV underperforms 65.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 39.31 | ||
| Altman-Z | 0.9 |
ROIC/WACC0.11
WACC7.17%
2.3 Liquidity
ZIMV has a Current Ratio of 2.37. This indicates that ZIMV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.37, ZIMV is in line with its industry, outperforming 43.32% of the companies in the same industry.
ZIMV has a Quick Ratio of 1.60. This is a normal value and indicates that ZIMV is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ZIMV (1.60) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
ZIMV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 142.11%, which is quite impressive.
ZIMV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.48%.
The Revenue for ZIMV have been decreasing by -15.69% on average. This is quite bad
EPS 1Y (TTM)142.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
3.2 Future
ZIMV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.19% yearly.
Based on estimates for the next years, ZIMV will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y46.72%
EPS Next 2Y24.97%
EPS Next 3Y18.19%
EPS Next 5YN/A
Revenue Next Year-0.36%
Revenue Next 2Y0.63%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.46, ZIMV is valued on the expensive side.
ZIMV's Price/Earnings ratio is a bit cheaper when compared to the industry. ZIMV is cheaper than 79.14% of the companies in the same industry.
When comparing the Price/Earnings ratio of ZIMV to the average of the S&P500 Index (26.99), we can say ZIMV is valued slightly cheaper.
A Price/Forward Earnings ratio of 20.43 indicates a rather expensive valuation of ZIMV.
Based on the Price/Forward Earnings ratio, ZIMV is valued a bit cheaper than the industry average as 78.07% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.36. ZIMV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.46 | ||
| Fwd PE | 20.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZIMV indicates a somewhat cheap valuation: ZIMV is cheaper than 77.01% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ZIMV is valued a bit cheaper than the industry average as 69.52% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 94.5 | ||
| EV/EBITDA | 16.65 |
4.3 Compensation for Growth
ZIMV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZIMV's earnings are expected to grow with 18.19% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y24.97%
EPS Next 3Y18.19%
5. Dividend
5.1 Amount
ZIMV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
18.82
-0.04 (-0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners84.88%
Inst Owner Change-5.07%
Ins Owners2.63%
Ins Owner Change25.13%
Market Cap530.72M
Analysts48.89
Price Target16.32 (-13.28%)
Short Float %2.31%
Short Ratio1.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.01%
Min EPS beat(2)21.96%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)32.05%
Min EPS beat(4)1.94%
Max EPS beat(4)78.25%
EPS beat(8)7
Avg EPS beat(8)120.45%
EPS beat(12)10
Avg EPS beat(12)160.71%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-3.18%
Max Revenue beat(2)1.35%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.35%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.38%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.3%
PT rev (3m)-32.48%
EPS NQ rev (1m)-8.2%
EPS NQ rev (3m)-11.06%
EPS NY rev (1m)0%
EPS NY rev (3m)0.43%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-2.65%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.46 | ||
| Fwd PE | 20.43 | ||
| P/S | 1.2 | ||
| P/FCF | 94.5 | ||
| P/OCF | 44.35 | ||
| P/B | 1.29 | ||
| P/tB | 8.83 | ||
| EV/EBITDA | 16.65 |
EPS(TTM)0.92
EY4.89%
EPS(NY)0.92
Fwd EY4.9%
FCF(TTM)0.2
FCFY1.06%
OCF(TTM)0.42
OCFY2.25%
SpS15.72
BVpS14.64
TBVpS2.13
PEG (NY)0.44
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -4.72% | ||
| ROCE | 0.97% | ||
| ROIC | 0.77% | ||
| ROICexc | 0.86% | ||
| ROICexgc | 2.21% | ||
| OM | 1.42% | ||
| PM (TTM) | N/A | ||
| GM | 65.31% | ||
| FCFM | 1.27% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 39.31 | ||
| Debt/EBITDA | 5.39 | ||
| Cap/Depr | 18.32% | ||
| Cap/Sales | 1.43% | ||
| Interest Coverage | 0.43 | ||
| Cash Conversion | 29.2% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.6 | ||
| Altman-Z | 0.9 |
F-Score6
WACC7.17%
ROIC/WACC0.11
Cap/Depr(3y)17.11%
Cap/Depr(5y)24.69%
Cap/Sales(3y)2.37%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y46.72%
EPS Next 2Y24.97%
EPS Next 3Y18.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
Revenue Next Year-0.36%
Revenue Next 2Y0.63%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y126.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.32%
EBIT Next 3Y44.17%
EBIT Next 5YN/A
FCF growth 1Y117.33%
FCF growth 3Y-0.91%
FCF growth 5Y-35.32%
OCF growth 1Y192.13%
OCF growth 3Y-39.59%
OCF growth 5Y-34.68%